The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force fo...

SPEAC has completed a fifth update to the Priority List of potential Adverse events of special interest relevant to COVID-19 vacci...

We are proud to announce that Dr. Bob Chen, Scientific Director of the Brighton Collaboration, received a special award for “Co...

To help meet its increasing needs, the Secretariat for the Brighton Collaboration (BC) has recently posted a new staff position:...

Coalition for Epidemic Preparedness Innovations (CEPI) through the Safety Platform for Emergency vACcines (SPEAC) project, has f...

On behalf of the COVAX Vaccine Safety Working group: After COVID-19 vaccines are introduced into countries, it will be vital to...

The current Brighton Collaboration Science Board has voted to accept all 16 candidates onto the new Brighton Collaboration Science...

SPEAC has completed a 4th update of the COVID-19 clinical literature covering the period from November 2020 – August 2021. Click...

We would like to announce the upcoming Brighton Collaboration Science Board election. The Science Board meets monthly for one hour...

As part of its role to support the assessment of safety of vaccines being evaluated in CEPI funded clinical trials, the Safety Pla...